Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Method and receiver structure for interference cancellation in co-ordinated multipoint systems
Image capturing system
Methods and apparatus for image analysis using threshold compactness features
Auxiliary cyclonic dust collector
Feature extraction device and feature extraction method
Phase-locked-loop with quadrature tracking filter for synchronizing an electric grid
Data latch circuit
  Randomly Featured Patents
2-aminoquinoline derivatives
Method and system for generating a space signature
High-speed laser cutting method with adapted gas
Device with shutter winding about a drum
Game apparatus and storage medium storing game program
Semiconductor memory device having level converters
Heat spreader with oscillating flow
Method and apparatus for cooking starch
Method of detecting the initial concentration of a water-treatment chemical in a diluted aqueous system